0001437749-23-011378.txt : 20230427 0001437749-23-011378.hdr.sgml : 20230427 20230427163021 ACCESSION NUMBER: 0001437749-23-011378 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230425 FILED AS OF DATE: 20230427 DATE AS OF CHANGE: 20230427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Narayan Prabhu CENTRAL INDEX KEY: 0001829831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38634 FILM NUMBER: 23857561 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER NAME: FORMER CONFORMED NAME: Parbhu Narayan DATE OF NAME CHANGE: 20201023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC. CENTRAL INDEX KEY: 0001742927 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 4085018881 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: Tenzing Acquisition Corp. DATE OF NAME CHANGE: 20180606 4 1 rdgdoc.xml FORM 4 X0407 4 2023-04-25 0001742927 REVIVA PHARMACEUTICALS HOLDINGS, INC. RVPH 0001829831 Narayan Prabhu C/O REVIVA PHARMACEUTICALS HOLDINGS, INC 19925 STEVENS CREEK BLVD, SUITE 100 CUPERTINO CA 95014 1 Chief Financial Officer 0 Stock Option (right to buy) 6.74 2023-04-25 4 A 0 170000 0 A 2033-04-24 Common Stock, par value $0.0001 per share 170000 170000 D Represents an option award granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the "Reporting Person"), by the Issuer's compensation committee on April 25, 2023 (the "Grant Date") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The option vested as to fifty percent (50%) of the shares subject thereto on the Grant Date, and will vest as to an additional 1.389% of the shares subject thereto on the last day of each month thereafter. The exercise price is based on the closing price of the Issuer's common stock on the Grant Date in accordance with the terms of the 2020 Plan. /s/ Narayan Prabhu 2023-04-27